Topics:
Hematologic Malignancies • Pediatric Oncology • Lymphoma • NCI-CCC Tumor Board Question • Hematology • UC Irvine • NCI-CCC Lymphoma Tumor Board Question
How would you manage a young, HIV-negative patient with good performance status with primary refractory Burkitt Lymphoma involving the CNS and systemic disease?
Progression after 5 cycles of R-daEPOCH and IT MTX. CNS negative and intermediate Burkitt IPI at initial presentation.